Summary:
We are currently looking for study volunteers to participate in a clinical trial involving and investigational medication for Type 2 Diabetes and Cardiac Risk Factors. This clinical trial consists of approximately 17 visits over a 2 year period. Compensation for time and travel is up to $850
Qualified Participants Must:
• Have type 2 diabetes
•
Be 18-85 years of age
•
Have been treated for at least 90 days with insulin (glargine, NPH, or detemir) in combination with oral antihyperglycemic agents as monotherapy, dual, or triple therapy (sulfonylurea, meglitinide, metformin, pioglitazone, or dipeptidyl peptidase-4 [DPP-4] inhibitor)
•
Be treated with insulin (glargine, NPH, or detemir) at least 20 U/day
•
Be willing to do the following: inject insulin with a prefilled pen and perform self blood glucose monitoring and record keeping as required
•
Not have used rapid- or short-acting insulin therapy within the past 6 months
•Cannot have a BMI >45
Qualified Participants May Receive:
All study related procedures, supplies and medications at no cost and compensation for time and travel up to $500.